FEATURED PRODUCT: Interpretation of FDA's (QSR) With QSIT references
A
complete compendium to FDA's Quality System Regulation (QSR) with relative
references to FDA's Quality System Inspection Technique (QSIT). Now ONLY $99 (limited time)
Search This Site
Conducting Clinical Investigations In Canada
Clinical Investigations pathway in Canada is determined
by the classification of your device. Obviously the higher the classification
the more you will require and the more safety precautions you will need for the
investigation.
In general, Class I devices can proceed to investigational testing without
applying to the Health Canada for approval. Nevertheless Records for
investigation testing of Class I devices need to be kept by the "seller" as per
Section 81 of the regulations. All other classified devices II, III and IV must
have TPD approval prior to commencing the investigation.
For additional information you can go the Health Canada's website:
http://www.hc-sc.gc.ca/dhp-mps/md-im/applic-demande/guide-ld/test_md3_im3_e.html
For In-Vitro Diagnostic Devices IVDD, the manufacturer should refer to the
specific Health Canada Guidance: "Preparation of an Application for
Investigational Testing - in Vitro Diagnostic Devices"
http://www.hc-sc.gc.ca/dhp-mps/md-im/applic-demande/guide-ld/test_iv3_e.html
Requirements for Safety and Effectiveness
Sections 10 to 20 of the Medical Devices Regulation set out the requirements for
ALL medical devices sold in Canada. To apply for an authorization to conduct
investigational testing on human subjects in Canada, a manufacturer and/or
device sponsor must use the application form in Appendix 1 of the document
"Preparation of an Application for Investigational Testing - Medical Devices".
Following review of the application and provided that the testing can be
conducted without seriously endangering the lives of patients, users or other
personnel, the minister may grant an authorization.
Other factors that go into the decision process include:
the testing is not contrary to the best interests of the patients and
the objective of the testing is achievable
investigational testing conforms to the principles of the Declaration of
Helsinki and the Medical Research Council's "Code of Ethical Conduct for
Research Involving Humans - May 1997."
The format for the submission is straight forward and is clearly stated in
Health Canada's guidance document (for format see Appendix 2 of: "Preparation of
an Application for Investigational Testing - Medical Devices")
Although Health Canada allows you to structure your application in a way that is
suited for your investigation they highly recommends providing the following
with your application.
- an executive summary
- table of contents
- discrete chapters appropriate for each class of medical device
If you do plan to deviate from their recommended format
it is advised to ask ahead for their permission. Applications are accepted
in either French or English.
A positive review on an application will result in a green light to proceed. The
approval is conditional provided that no changes occur to the protocol, identity
of the qualified investigations, the institution as well as the type of
diagnosis or treatment for which the device is sold. Any changes to any one of
these criteria will require that you resubmit additional information BEFORE
actually making the changes.
Denied Approvals
Clinical Investigations are usually denied in cases where the device cannot be
used safely during the testing. Other reasons include situations where the
investigational testing is not in the best interest of the patients or if the
objective of the testing cannot be achieved.
In all cases - Health Canada does allow the manufacturer the right to appeal the
decision.
Confidentiality of Applications
Health Canada keeps all information submitted as part of the application in
strict confidentiality. This is their policy regarding pre and post
authorization. Hence you can be assured that all trade secrets, scientific,
technical as well as commercial or financial information is kept confidential.
Device Labeling
As part of the application for investigational testing in Canada, the
manufacturer (or device sponsor) must submit a copy of the device labeling. This
includes product monograph and all advertising brochures intended to be used
with the device.
In Particular, Health Canada will also want to see the labeling that will be
given to the qualified inspector and/or the patient. It is important per
Subsections 86(c) and 86(d) that the following statements "Investigational
Device" and "To be Used by Qualified Investigators Only" and "Instrument de
recherche" and "Réservé uniquement à l'usage de chercheurs compétents" be
present in BOTH English and French. This is important whether or not the testing
is conducted in Quebec or not. Health Canada want to see both set's of warnings.
Note: In the case of investigational testing of IVDD Subsection 86(e) requires
the Statement (again in both English and French): "The performance
specifications of this product have not been established" and "Les
spécifications de rendement de l'instrument n'ont pas été établies"
For Class III and IV investigational testing written approval from each proposed
institution's Research Ethics Board must be provided with the application. A
provisional investigational testing authorization may be granted by Health
Canada conditional on the receipt of a Research Ethics Board approval. In such
cases testing must not begin until the Ethics Board approval has been given.
In circumstances where the institution lacks a Research Ethics Board, an Ethics
Committee conforming with the Medical Research Council Guideline on the "Code of
Ethical Conduct for Research Involving Humans." Must be convened. A guideline on
how to set up this comittee is available on the MRC website at http://www.cihr-irsc.gc.ca
or by contacting the MRC at Holland Cross, Tower B, 5th Floor, 1600 Scott
Street, Postal Locator 3105A, Ottawa, Ontario K1A 0W9.
In conclusion, products undergoing investigational testing in Canada must follow
specific Health Canada requirements and guidance. For Class II and higher
devices, the manufacturer must obtain Health Canada's approval before commencing
any testing on humans. For Class III and IV devices, the manufacturer or device
sponsor is also required to obtain the institution's Research Ethics Board
review and approval.
Specific questions or concerns they are urged to contact the Manager, Device
Evaluation Division, Medical Devices Bureau at (613) 954-0297.
Site Map »
Media package available for advertisers looking to advertise on this site.